SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 336 participants.
Also called NCT05583773
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 336 participants
- Registry
-
NCT05583773
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05583773. Randomized; double masking; primary purpose treatment. Start 2023-03-29 (actual); primary completion 2027-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
- Acronym
- SHINE-HF
- Condition
- Heart Failure
- Intervention (Drug)
- ShengXian-QuYu Decoction
- Intervention (Other)
- Placebo
- Lead sponsor
- China-Japan Friendship Hospital
Record details
- Record id
cardio:ct-nct05583773- Content hash
0bb73d6cacd0309ba16de4929196c446f01625585033f618417c16123b360afd